Compassionate Use of Campath-1H in Treating Patients With Refractory Prolymphocytic Leukemia or Chronic Lymphocytic Leukemia

This study has been completed.
National Cancer Institute (NCI)
Genzyme, a Sanofi Company
Information provided by (Responsible Party):
Case Comprehensive Cancer Center Identifier:
First received: July 11, 2001
Last updated: January 7, 2014
Last verified: January 2014
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: May 2002
  Primary Completion Date: April 2001 (Final data collection date for primary outcome measure)